Intrinsic bioenergetic adaptations compensate for reduced mitochondrial content in HER2-driven mammary tumors

作者：Sara M. Frangos, Henver S. Brunetta, Dongdong Wang, Maria Joy Therese Jabile, David W.L., William J. Muller, Cezar M. Khursigara, Kelsey H. Fisher‐Wellman, Gregory R. Steinberg, Graham P. Holloway · 发表于：eLife · 年份：2025 · DOI：10.7554/elife.104079.1 · 被引用次数：1 · 研究领域：Cancer, Hypoxia, and Metabolism、Cancer-related Molecular Pathways、Medical Imaging Techniques and Applications

Abstract It is now recognized that mitochondria play a crucial role in tumorigenesis, however, it has become clear that tumor metabolism varies significantly between cancer types. The failure of recent clinical trials attempting to directly target tumor respiration with inhibitors of oxidative phosphorylation has highlighted the critical need for additional studies comprehensively assessing mitochondrial bioenergetics. Therefore, we systematically assessed the bulk tumor and mitochondrial metabolic phenotype between murine HER2-driven mammary cancer tumors and paired benign mammary tissue. Transcriptomic and proteomic profiling revealed that HER2-driven mammary tumors are characterized by a downregulation of mitochondrial genes/proteins compared to benign mammary tissue, including a general downregulation of OXPHOS subunits comprising Complexes I-IV. Despite this observation, mitochondrial respiration supported by both carbohydrate-derived substrates (pyruvate) and lipids (palmitoyl-carnitine) was several-fold higher in HER2-driven tumors which persisted regardless of normalization method (i.e. wet weight, total protein content and when corrected for mitochondrial content). This upregulated respiratory capacity could not be explained by OXPHOS uncoupling; however, several subunits/regulators of Complex V function were not downregulated in the tumors, suggesting possible compensatory effects may contribute to high respiratory rates. Furthermore, tumor mitochondria displayed a ...